A. Ménez

501 total citations
17 papers, 422 citations indexed

About

A. Ménez is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, A. Ménez has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 2 papers in Pharmacology. Recurrent topics in A. Ménez's work include Venomous Animal Envenomation and Studies (9 papers), Ion channel regulation and function (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). A. Ménez is often cited by papers focused on Venomous Animal Envenomation and Studies (9 papers), Ion channel regulation and function (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). A. Ménez collaborates with scholars based in France, United Kingdom and Japan. A. Ménez's co-authors include Christian Roumestand, F. Toma, Serge Chwetzoff, Fumio Sakiyama, Susumu Tsunasawa, Jean‐Claude Boulain, Alan L. Harvey, Bernard Maillère, Gilles Mourier and J. P. Cotton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

A. Ménez

17 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ménez France 10 324 194 53 48 47 17 422
Shigeyuki Terada Japan 13 334 1.0× 132 0.7× 25 0.5× 30 0.6× 12 0.3× 56 509
Corrine Seebart United States 13 372 1.1× 239 1.2× 52 1.0× 22 0.5× 9 0.2× 15 509
Sandrine Braud France 11 468 1.4× 320 1.6× 165 3.1× 24 0.5× 14 0.3× 16 712
Yongxiang Gao China 17 506 1.6× 105 0.5× 14 0.3× 37 0.8× 16 0.3× 51 732
Jinyun Xie China 10 362 1.1× 225 1.2× 20 0.4× 26 0.5× 5 0.1× 11 457
Weijun Hu China 16 599 1.8× 400 2.1× 46 0.9× 35 0.7× 9 0.2× 23 757
K D Elgert United States 7 100 0.3× 86 0.4× 62 1.2× 149 3.1× 7 0.1× 10 362
S. Liang China 9 278 0.9× 196 1.0× 34 0.6× 31 0.6× 4 0.1× 19 378
Dahe Jiang China 10 279 0.9× 216 1.1× 14 0.3× 29 0.6× 11 0.2× 23 373
Albetiza Lôbo de Araújo Brazil 11 155 0.5× 347 1.8× 111 2.1× 19 0.4× 3 0.1× 13 443

Countries citing papers authored by A. Ménez

Since Specialization
Citations

This map shows the geographic impact of A. Ménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ménez more than expected).

Fields of papers citing papers by A. Ménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ménez. The network helps show where A. Ménez may publish in the future.

Co-authorship network of co-authors of A. Ménez

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ménez. A scholar is included among the top collaborators of A. Ménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ménez. A. Ménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Magis, Cedrik, Alain Lecoq, Marie‐Hélène Le Du, et al.. (2006). Structure-Based Secondary Structure-Independent Approach To Design Protein Ligands:  Application to the Design of Kv1.2 Potassium Channel Blockers. Journal of the American Chemical Society. 128(50). 16190–16205. 14 indexed citations
2.
Belin, Pascal, et al.. (2004). Toxicity-based selection of Escherichia coli mutants for functional recombinant protein production: application to an antibody fragment. Protein Engineering Design and Selection. 17(5). 491–500. 9 indexed citations
3.
Du, Marie‐Hélène Le, Bruno Müller, Oleg V. Bulgakov, et al.. (2002). Artificial Evolution of an Enzyme Active Site: Structural Studies of Three Highly Active Mutants of Escherichia coli Alkaline Phosphatase. Journal of Molecular Biology. 316(4). 941–953. 32 indexed citations
4.
Servent, Denis, et al.. (1998). How do snake curaremimetic toxins discriminate between nicotinic acetylcholine receptor subtypes. Toxicology Letters. 102-103. 199–203. 13 indexed citations
5.
Cotton, J. P., et al.. (1998). Pseudopeptide ligands for MHC II-restricted T cells.. International Immunology. 10(2). 159–166. 18 indexed citations
6.
Chippaux, Jean‐Philippe, et al.. (1997). [Genetic origin of venom variability: impact on the preparation of antivenin serums].. PubMed. 90(4). 277–81. 11 indexed citations
7.
Ayeb, Mohamed El, Habib Karoui, F. Ducancel, et al.. (1996). Multidisciplinary approach for immunoprevention of scorpion envenomation. Toxicon. 34(2). 149–149. 1 indexed citations
8.
Harvey, Alan L., Hossein Vatanpour, Edward G. Rowan, et al.. (1995). Structure-activity studies on scorpion toxins that block potassium channels. Toxicon. 33(4). 425–436. 30 indexed citations
9.
Roumestand, Christian, et al.. (1995). Scorpion toxins as natural scaffolds for protein engineering.. Proceedings of the National Academy of Sciences. 92(14). 6404–6408. 122 indexed citations
10.
Gasparini, Sylvaine, N.I. Kiyatkin, Pascal Drevet, et al.. (1994). The low molecular weight protein which co-purifies with alpha-latrotoxin is structurally related to crustacean hyperglycemic hormones.. Journal of Biological Chemistry. 269(31). 19803–19809. 46 indexed citations
11.
Maillère, Bernard, et al.. (1993). Role of thiols in the presentation of a snake toxin to murine T cells. The Journal of Immunology. 150(12). 5270–5280. 18 indexed citations
12.
Rowan, Edward G., Alan L. Harvey, & A. Ménez. (1991). Neuromuscular effects of nigexine, a basic phospholipase A2 from Naja nigricollis venom. Toxicon. 29(3). 371–374. 8 indexed citations
13.
Chwetzoff, Serge, Susumu Tsunasawa, Fumio Sakiyama, & A. Ménez. (1989). Nigexine, a Phospholipase A2 from Cobra Venom with Cytotoxic Properties Not Related to Esterase Activity. Journal of Biological Chemistry. 264(22). 13289–13297. 91 indexed citations
14.
Chwetzoff, Serge, Takeshi Minami, P. Fromageot, & A. Ménez. (1988). [Basic phospholipase from the venom of Naja nigricollis is cytotoxic].. PubMed. 306(2). 31–3. 3 indexed citations
15.
Chwetzoff, Serge & A. Ménez. (1988). [Lethal in vivo and cytotoxic in vitro properties of a basic phospholipase A2 modified with para-bromophenacyl bromide].. PubMed. 307(2). 29–32. 2 indexed citations
16.
Beaudet, Alain, O. Trémeau, A. Ménez, & Brian A. Droz. (1979). [Visualization of opiate receptors in the locus coeruleus of rats: high resolution radioautography after administration of a tritiated met-enkephalin analog].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 289(7). 591–4. 1 indexed citations
17.
Weber, Michel, A. Ménez, P. Fromageot, P Boquet, & Changeux Jp. (1972). [Effect of cholinergic agents and local anesthetics on the kinetics of binding of tritiated toxin of Naja nigricollis to the cholinergic receptor].. PubMed. 274(10). 1575–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026